189 related articles for article (PubMed ID: 31459371)
1. Structural Modeling and in Silico Screening of Potential Small-Molecule Allosteric Agonists of a Glucagon-like Peptide 1 Receptor.
Redij T; Chaudhari R; Li Z; Hua X; Li Z
ACS Omega; 2019 Jan; 4(1):961-970. PubMed ID: 31459371
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
Redij T; Ma J; Li Z; Hua X; Li Z
J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
[TBL] [Abstract][Full Text] [Related]
3. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
Cheong YH; Kim MK; Son MH; Kaang BK
Biochem Biophys Res Commun; 2012 Jan; 417(1):558-63. PubMed ID: 22177947
[TBL] [Abstract][Full Text] [Related]
4. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
Willard FS; Ho JD; Sloop KW
Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
[TBL] [Abstract][Full Text] [Related]
5. Ligand-Receptor Interactions and Machine Learning in GCGR and GLP-1R Drug Discovery.
Mizera M; Latek D
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920024
[TBL] [Abstract][Full Text] [Related]
6. Transmembrane α-helix 2 and 7 are important for small molecule-mediated activation of the GLP-1 receptor.
Rye Underwood C; Møller Knudsen S; Schjellerup Wulff B; Bräuner-Osborne H; Lau J; Knudsen LB; Peters GH; Reedtz-Runge S
Pharmacology; 2011; 88(5-6):340-8. PubMed ID: 22134089
[TBL] [Abstract][Full Text] [Related]
7. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
Nakane A; Gotoh Y; Ichihara J; Nagata H
Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
[TBL] [Abstract][Full Text] [Related]
8. Structural insight into antibody-mediated antagonism of the Glucagon-like peptide-1 Receptor.
Hennen S; Kodra JT; Soroka V; Krogh BO; Wu X; Kaastrup P; Ørskov C; Rønn SG; Schluckebier G; Barbateskovic S; Gandhi PS; Reedtz-Runge S
Sci Rep; 2016 May; 6():26236. PubMed ID: 27196125
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.
Graaf Cd; Donnelly D; Wootten D; Lau J; Sexton PM; Miller LJ; Ahn JM; Liao J; Fletcher MM; Yang D; Brown AJ; Zhou C; Deng J; Wang MW
Pharmacol Rev; 2016 Oct; 68(4):954-1013. PubMed ID: 27630114
[TBL] [Abstract][Full Text] [Related]
10. A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain.
Tibaduiza EC; Chen C; Beinborn M
J Biol Chem; 2001 Oct; 276(41):37787-93. PubMed ID: 11498540
[TBL] [Abstract][Full Text] [Related]
11. The putative binding site and SAR rationalization of small molecules against glucagon-like peptide-1 receptor using homology model and crystal structures: a comparative study.
Thamaraiselvan V; Velayutham R
J Biomol Struct Dyn; 2022 Mar; 40(5):2038-2052. PubMed ID: 33118484
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
Thompson A; Kanamarlapudi V
Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
[TBL] [Abstract][Full Text] [Related]
13. Non-peptide agonists and positive allosteric modulators of glucagon-like peptide-1 receptors: Alternative approaches for treatment of Type 2 diabetes.
Malik F; Li Z
Br J Pharmacol; 2022 Feb; 179(4):511-525. PubMed ID: 33724441
[TBL] [Abstract][Full Text] [Related]
14. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators.
Song G; Yang D; Wang Y; de Graaf C; Zhou Q; Jiang S; Liu K; Cai X; Dai A; Lin G; Liu D; Wu F; Wu Y; Zhao S; Ye L; Han GW; Lau J; Wu B; Hanson MA; Liu ZJ; Wang MW; Stevens RC
Nature; 2017 Jun; 546(7657):312-315. PubMed ID: 28514449
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of peptidomimetic agonism revealed by small- molecule GLP-1R agonists Boc5 and WB4-24.
Cong Z; Zhou Q; Li Y; Chen LN; Zhang ZC; Liang A; Liu Q; Wu X; Dai A; Xia T; Wu W; Zhang Y; Yang D; Wang MW
Proc Natl Acad Sci U S A; 2022 May; 119(20):e2200155119. PubMed ID: 35561211
[TBL] [Abstract][Full Text] [Related]
16. Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery.
Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
J Pharmacol Exp Ther; 2015 Apr; 353(1):52-63. PubMed ID: 25630467
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule agonists for the glucagon-like peptide 1 receptor.
Knudsen LB; Kiel D; Teng M; Behrens C; Bhumralkar D; Kodra JT; Holst JJ; Jeppesen CB; Johnson MD; de Jong JC; Jorgensen AS; Kercher T; Kostrowicki J; Madsen P; Olesen PH; Petersen JS; Poulsen F; Sidelmann UG; Sturis J; Truesdale L; May J; Lau J
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):937-42. PubMed ID: 17213325
[TBL] [Abstract][Full Text] [Related]
18. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
[TBL] [Abstract][Full Text] [Related]
19. A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.
Chen D; Liao J; Li N; Zhou C; Liu Q; Wang G; Zhang R; Zhang S; Lin L; Chen K; Xie X; Nan F; Young AA; Wang MW
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):943-8. PubMed ID: 17213311
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R).
Méndez M; Matter H; Defossa E; Kurz M; Lebreton S; Li Z; Lohmann M; Löhn M; Mors H; Podeschwa M; Rackelmann N; Riedel J; Safar P; Thorpe DS; Schäfer M; Weitz D; Breitschopf K
J Med Chem; 2020 Mar; 63(5):2292-2307. PubMed ID: 31596080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
